Sentences with phrase «health oversight which»

Not exact matches

Similar to the Company, Dignity Health is subject to significant regulatory oversight, which provides Mr. Dean with additional insight in analyzing and advising on complex regulatory issues affecting the Company.

This risk is overlooked when considering safe outcomes for birth based on birth site, which is an incredible oversight considering the U.S. Department of Health and Human Services» has recently concluded that 9.5 % of all deaths each year in the U.S. stems from a medical error.

Her former position as the State Breastfeeding Coordinator supported and promoted breastfeeding endeavors for all of the Commonwealth of Virginia, which includes the development of public policy and media campaigns, curricula, publications and training; oversight of the Virginia WIC Breastfeeding Peer Counselor Program; and service as the Virginia Department of Health liaison to the Virginia Breastfeeding Advisory Committee.

Worse, most health and sex education classes don't cover the basics of lactation when teaching about reproduction which, you know, is a glaring oversight.

· In 2014, the jail's Special Housing Unit (a disciplinary block) was reviewed by the New York State Commission of Correction, the oversight agency for jails statewide, and earned a «merited commendation» from the commission, which noted mental health operations in particular.

That was the unexpected outcome of a meeting convened last week in Geneva, Switzerland, by the World Health Organization (WHO), which also promised to create a more rigorous oversight system for such research.

The health crisis, which has led to more than 200 infections, could lead to shift from state to federal oversight of compounding pharmacies.

While the tritium spikes don't represent a health threat, I agree with Lochbaum on the need for significant changes in oversight, which he characterizes this way below: «The N.R.C. should enforce its regulations or change its name to N.C.»

Medical malpractice may involve a variety of errors and oversights which prove detrimental to the patient's health:

(H) There are adequate written assurances that the protected health Start Printed Page 82817information will not be reused or disclosed to any other person or entity, except as required by law, for authorized oversight of the research project, or for other research for which the use or disclosure of protected health information would be permitted by this subpart.

However, we believe that requiring covered entities to obtain extensive documentation of health oversight information needs could compromise health oversight agencies» ability to complete investigations, particularly when an oversight agency is investigating the covered entity from which it is seeking information.

When a covered entity was also an oversight agency, it also would have been permitted to use protected health information in all cases in which it would have been allowed to disclose such information for health oversight purposes.

In the final rule, we include a waiver criterion requiring «there are adequate written assurances that the protected health information will not be re-used or disclosed to any other person or entity, except as required by law, for authorized oversight of the research project, or for other research for which the use or disclosure of protected health information would be permitted by this subpart.»

We reviewed the important purposes for which some commenters said government agencies needed protected health information, and we believe that most of those needs can be met through the other categories of permitted uses and disclosures without authorization allowed under the final rule, including provisions permitting covered entities to disclose information (subject to certain limitations) to government agencies for public health, health oversight, law enforcement, and otherwise as required by law.

Health oversight agency means an agency or authority of the United States, a State, a territory, a political subdivision of a State or territory, or an Indian tribe, or a person or entity acting under a grant of authority from or contract with such public agency, including the employees or agents of such public agency or its contractors or persons or entities to whom it has granted authority, that is authorized by law to oversee the health care system (whether public or private) or government programs in which health information is necessary to determine eligibility or compliance, or to enforce civil rights laws for which health information is relHealth oversight agency means an agency or authority of the United States, a State, a territory, a political subdivision of a State or territory, or an Indian tribe, or a person or entity acting under a grant of authority from or contract with such public agency, including the employees or agents of such public agency or its contractors or persons or entities to whom it has granted authority, that is authorized by law to oversee the health care system (whether public or private) or government programs in which health information is necessary to determine eligibility or compliance, or to enforce civil rights laws for which health information is relhealth care system (whether public or private) or government programs in which health information is necessary to determine eligibility or compliance, or to enforce civil rights laws for which health information is relhealth information is necessary to determine eligibility or compliance, or to enforce civil rights laws for which health information is relhealth information is relevant.

To clarify further that health oversight disclosure rules apply generally in health care fraud investigations (subject to the exception described above), in the final rule, we eliminate proposed § 164.510 (f)(5)(i), which would have established requirements for disclosure related to health fraud for law enforcement purposes.

For example, if a state insurance department is acting as a health plan in operating the state's Medicaid managed care program, the final rule allows the insurance department to use protected health information in all cases for which the plan can disclose the protected health information for health oversight purposes.

The proposed rule listed the Social Security Administration and the Department of Education as examples of health oversight agencies that conduct oversight of government benefit programs for which health information is relevant to beneficiary eligibility.

In addition, in the final rule, we add «licensure or disciplinary actions» to the list of oversight activities authorized by law for which covered entities may disclose protected health information to health oversight agencies.

Thus, the final rule includes agencies that are authorized by law to «enforce civil rights laws for which health information is relevant» in the definition of «health oversight agency» at § 164.501.

We make this change in the regulation text of the final rule to conform to the NPRM's definition of health oversight agency and to reflect the full range of activities for which we intend to allow covered entities to disclose protected health information to health oversight agencies.

This section indicates that health oversight activities do not include an investigation or activity in which the individual is the subject of the investigation or activity and the investigation or activity does not arise out of and is not directly related to health care fraud.

The proposed rule listed the Occupational Health and Safety Administration and the Environmental Protection Agency as examples of oversight agencies that conduct oversight of government regulatory programs for which health information is necessary for determining compliance with program stanHealth and Safety Administration and the Environmental Protection Agency as examples of oversight agencies that conduct oversight of government regulatory programs for which health information is necessary for determining compliance with program stanhealth information is necessary for determining compliance with program standards.

To clarify further that health oversight disclosure rules apply generally in health care fraud investigations (subject to the exception described above), in the final rule, we eliminate proposed § 164.510 (f)(5)(i), which would have established requirements for disclosure related to health care fraud for law enforcement purposes.

Response: In the final rule, we have added an additional waiver criteria to require that there are adequate written assurances from the researcher that protected health information will not be re-used or disclosed to any other person or entity, except as required by law, for authorized oversight of the research project, or for other research for which the use or disclosure of protected health information would be permitted by this subpart.

In the final rule, we add new language (§ 164.512 (d)(3)-RRB- to address situations in which health oversight activities are conducted in conjunction with an investigation regarding a claim for public benefits not related to health (e.g., claims for Food Stamps).

In describing «other activities necessary for oversight» of particular entities, we add the phrase «entities subject to civil rights laws for which health information is necessary for determining compliance.»

«Overseeing the health care system,» which is included in the definition of health oversight, encompasses activities such as: oversight of health care plans; oversight of health benefit plans; oversight of health care providers; oversight of health care and health care delivery; oversight activities that involve resolution of consumer complaints; oversight of pharmaceuticals, medical products and devices, and dietary supplements; and a health oversight agency's analysis of trends in health care costs, quality, health care delivery, access to care, and health insurance coverage for health oversight purposes.

For the purpose of the disclosures permitted by paragraph (d)(1) of this section, a health oversight activity does not include an investigation or other activity in which the individual is the subject of the investigation or activity and such investigation or other activity does not arise out of and is not directly related to:

Comment: Many commenters noted that proposed § 164.510 (f)(5)(i), which covered disclosures for investigations and prosecutions of health care fraud, overlapped with proposed § 164.510 (c) which covered disclosures for health oversight activities.

The new § 164.512 includes paragraphs on: Uses and disclosures required by law; uses and disclosures for public health activities; disclosures about victims of abuse, neglect, or domestic violence; uses and disclosures for health oversight activities; disclosures for judicial and administrative proceedings; disclosures for law enforcement purposes; uses and disclosures about decedents; uses and disclosures for cadaveric donation of organs, eyes, or tissues; uses and disclosures for research purposes; uses and disclosures to avert a serious threat to health or safety (which we had called «emergency circumstances» in the NPRM); uses and disclosures for specialized government functions (referred to as «specialized classes» in the NPRM); and disclosures to comply with workers» compensation laws.

The proposed rule would have defined «health oversight agency» as «an agency, person, or entity, including the employees or agents thereof, (1) That is: (i) A public agency; or (ii) A person or entity acting under grant of authority from or contract with a public agency; and (2) Which performs or oversees the performance of any audit; investigation; inspection; licensure or discipline; civil, criminal, or administrative proceeding or action; or other activity necessary for appropriate oversight of the health care system, of government benefit programs for which health information is relevant to beneficiary eligibility, or of government regulatory programs for which health information is necessary for determining compliance with program standards.&rWhich performs or oversees the performance of any audit; investigation; inspection; licensure or discipline; civil, criminal, or administrative proceeding or action; or other activity necessary for appropriate oversight of the health care system, of government benefit programs for which health information is relevant to beneficiary eligibility, or of government regulatory programs for which health information is necessary for determining compliance with program standards.&rwhich health information is relevant to beneficiary eligibility, or of government regulatory programs for which health information is necessary for determining compliance with program standards.&rwhich health information is necessary for determining compliance with program standards.»

The final rule requires that the covered entity obtain written agreement from the person or entity receiving protected health information under § 164.512 (i) not to re-use or disclose protected health information to any other person or entity, except: (1) As required by law, (2) for authorized oversight of the research project, or (3) for other research for which the use or disclosure of protected health information would be permitted by this subpart.

Government contractors such as coding committees, which provide data to HCFA to support payment processes, are not thereby health oversight agencies under this rule.

We apply more extensive procedural requirements to law enforcement disclosures than to disclosures for health oversight because we believe that law enforcement investigations more often involve situations in which the individual is the subject of the investigation (and thus could suffer adverse consequences), and we believe that it is appropriate to provide greater protection to individuals in such cases.

As in the NPRM, the final rule provides that when a covered entity is also an oversight agency, it is allowed to use protected health information in all cases in which it is allowed to disclose such information for health oversight purposes.

This includes: (1) Involvement with multiple drug distribution functions (inclusive of computerized physician order entry and / or prospective review and verification of physicians» orders, IV admixture preparation, etc.)(2) Defined clinical activities to optimize therapeutic outcomes under the guidance of the departmental and corporate directives (which include active communication with physicians, nurses, and other healthcare staff about the need to clarify and / or change an order along with documentation of intervention outcomes)(3) Educational activities with pharmacist colleagues and other health care professionals (e.g., physicians, nurses, etc.) to maintain and advance clinical competencies (4) Supervise and provide oversight and direction of technicians» drug preparation and distribution activities to assure safe and expedient provision of pharmaceutical care to patients and staff.

The National Evaluation of the Court Improvement Program U.S. Department of Health and Human Services, Children's Bureau, & Planning and Learning Technologies (Pal - Tech)(2006) Provides information on the National Evaluation of the Court Improvement Program, which describes how State courts improve their oversight of foster care and adoption cases and analyze the outcomes achieved.

The state's premier professional association for LMHCs and RMHCIs is the Florida Mental Health Counselors Association, which seeks to «provide education, legislative oversight, and networking» for the field.